Checked Sep 14, 2026
GLP-1 pill vs. shot. What the Wegovy oral launch actually changes about cost and convenience.
The Wegovy pill costs $149 a month at the 1.5mg starter dose through NovoCare, $199 at 4mg, and $299 at 9mg and at 25mg, the dose you stay on.
Two cash programs to check, priced for the weekly shot.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →
- Shed$199 a monthcompounded semaglutideCheck price →A health form first, then you choose your plan
For three years, the GLP-1 choice was binary: injectable or nothing. The 2026 FDA approval of the Wegovy pill (oral semaglutide for weight management) changed that.
It is cheaper at maintenance than the injectable Wegovy and costs more than compounded injectable semaglutide. Whether it belongs in your plan depends on three numbers: what you are paying now, whether you inject weekly, and whether you have insurance covering one format but not the other.
- The Wegovy pill ($299/mo at maintenance) is cheaper than the Wegovy injection ($349-$399/mo) at the same NovoCare cash price point.
- Compounded injectable semaglutide is still cheaper than the pill at $149-$249/mo from the main telehealth programs, but it is not FDA-approved and carries supply risk.
- Rybelsus is not the Wegovy pill. Rybelsus is oral semaglutide with a type 2 diabetes indication. It has no weight-loss indication and costs about $998 a month cash.
- Tirzepatide (Zepbound) has the strongest published weight-loss result of any injectable here. SURMOUNT-1 measured about 20% average weight loss at 15mg a week, against about 15% for injectable semaglutide in STEP 1. Those are separate clinical trials in different populations.
- The Wegovy pill's $149 price covers the 1.5mg starter dose only. The 4mg step is $199/month and maintenance is $299/month.
What the 2026 oral approval actually changed
The Wegovy pill is not Novo Nordisk's first oral semaglutide. That was Rybelsus (2019), a 3mg to 14mg tablet for type 2 diabetes that doctors sometimes prescribed off-label for weight management. It costs about $998 a month cash without insurance. The Wegovy pill is a distinct product, approved specifically for chronic weight management, with a dedicated NovoCare cash program pricing it at $149/mo for the 1.5mg starter dose and $299/month for maintenance.
That $299 maintenance price matters because the branded injectable path through NovoCare runs $349-$399/month after the intro period. For a cash-pay patient on branded semaglutide, switching from the shot to the pill saves $50-$100 a month. It is the same molecule from the same manufacturer, held to the same regulatory approval standard. The tradeoff is a daily pill taken on an empty stomach instead of a once-weekly injection.
Compounded injectable semaglutide still undercuts both, from $149/mo at the cheapest telehealth programs. But that comparison involves a different regulatory chain: 503A-compounded, not FDA-approved, with supply continuity tied to pharmacy compliance and ongoing litigation around tirzepatide.
Every format compared
Prices checked Sep 14, 2026. Cash prices only. Insurance copays excluded.
| Format | Regulatory status | Cash price | Dosing schedule | Availability |
|---|---|---|---|---|
| Compounded semaglutide (injectable) | Not FDA-approved (503A pharmacy) | From $149/mo Strut Health, with auto-refill; Shed $199 flat | Weekly self-injection | Most US telehealth programs; supply risk under litigation |
| Wegovy injection (branded) | FDA-approved (Novo Nordisk) | $349-$399/mo NovoCare cash, after intro offer; intro $199/mo for the first 2 fills at 0.25mg and 0.5mg, new patients, through Dec 31 2026 | Weekly self-injection (0.25mg-2.4mg) | Broad; insurance coverage growing after CMS ruling |
| Wegovy pill (oral, branded) | FDA-approved (Novo Nordisk, 2026) | $149/mo starter / $299/mo maintenance NovoCare: $149 for the 1.5mg starter dose, $199 for 4mg, $299 for 9mg and for 25mg, the dose you stay on | Daily oral tablet, empty stomach | Hims, Ro, WeightWatchers Clinic, Knownwell, NovoCare direct |
| Ozempic (injectable semaglutide, T2D) | FDA-approved for T2D (Novo Nordisk) | about $998/mo cash without insurance Retail pharmacy; NovoCare savings card requires T2D Rx | Weekly self-injection (0.25mg-2mg) | Requires T2D diagnosis for on-label prescribing |
| Rybelsus (oral semaglutide, T2D) | FDA-approved for T2D (Novo Nordisk, 2019) | about $998/mo cash without insurance Cash retail, read June 15, 2026; covered with T2D diagnosis | Daily oral tablet, empty stomach | Requires T2D diagnosis for on-label prescribing |
| Mounjaro / Zepbound injection (tirzepatide) | FDA-approved: Zepbound (weight loss), Mounjaro (T2D) | Zepbound: $299-$449/mo (vials), $449/mo (KwikPen) LillyDirect cash, read June 15, 2026. Mounjaro needs a type 2 diabetes prescription and we publish no cash counter price for it. | Weekly self-injection (2.5mg-15mg) | Zepbound via telehealth for weight loss; Mounjaro requires T2D Rx |
| Compounded tirzepatide (injectable) | Not FDA-approved (503A pharmacy) | From $149/mo Strut Health, with auto-refill; Henry Meds $299 flat at every dose; under active Lilly litigation | Weekly self-injection | Limited; FDA enforcement and Lilly litigation create supply risk |
Source: the price behind each row plus the NovoCare and LillyDirect cash programs, verified against the GLP Chart Price Index, checked every Monday.
The cost picture, format by format
Compounded injectable semaglutide: cheapest cash path
The cheapest all-in price for a semaglutide program in the US is $149/month (Strut Health, compounded injectable semaglutide, with auto-refill). Shed runs $199/month, flat across every dose tier.
That flat rate is what makes compounded competitive across the full titration arc. Most programs price by dose tier, so the starter dose is cheap and the maintenance dose is more expensive. The gap between compounded and branded at the maintenance dose runs $121-$221/month depending on the program.
Compounded semaglutide is made by a 503A pharmacy against a prescription. The FDA has not reviewed it for safety, effectiveness or quality. The risk is regulatory and supply: a 503A pharmacy operates outside the branded supply chain, and an FDA enforcement action or court order can halt supply quickly. That happened with compounded tirzepatide pharmacies in 2025.
Branded injectable Wegovy: the established cash path
The branded injectable Wegovy costs $349-$399/month through NovoCare at a maintenance dose. The injection comes in pre-filled pens at 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg, titrating over 16 weeks. For patients with insurance covering Wegovy, the injection is the dominant path because coverage is keyed to the branded injection NDA. The pill may or may not be covered under the same benefit, depending on how the insurer coded it.
Several telehealth programs dispense branded Wegovy injection alongside the pill: Hims, Ro,WeightWatchers Clinic, and Noom Med. The telehealth program membership fee adds $74-$149/month on top of the NovoCare medication price, so the all-in cash price at these programs runs $448-$548/month at maintenance.
Wegovy pill: the new cash math
The pill is available directly via NovoCare without a telehealth program membership, which shaves the membership cost out of the all-in number. Several programs also dispense it: Hims($149 membership adds $149/mo), Ro ($149/mo membership month to month, $74/mo prepaid for 12 months), WeightWatchers Clinic ($25-$74/mo membership). Run the math at your specific program; membership costs matter as much as the NovoCare pill price.
The pill requires a specific administration protocol: one tablet on an empty stomach with up to 4 oz of plain water, at least 30 minutes before eating, drinking anything other than water, or taking other medications. Missing that window reduces absorption. Patients who travel frequently, eat breakfast early, or take morning medications will find the daily injection-free routine trades one inconvenience for another.
Zepbound (tirzepatide): highest efficacy, injectable only
Tirzepatide remains injectable-only as of this writing. There is no approved oral tirzepatide for weight loss. Zepbound vials run $299-$449/month through LillyDirect depending on dose; the KwikPen version runs $449/month. Compounded tirzepatide starts at $149/month, with auto-refill through Strut Health, but carries active FDA enforcement and Lilly litigation risk.
For patients who tolerate injectable semaglutide but plateau or underrespond, tirzepatide's dual GIP/GLP-1 agonist mechanism has shown stronger weight outcomes in the SURMOUNT-1 trial (about 20% average weight loss at 15mg/week at 72 weeks). That efficacy advantage does not exist between injectable semaglutide and the oral Wegovy pill at the same doses.
Efficacy: what the clinical trials actually show
A direct head-to-head trial between the Wegovy pill and the Wegovy injection has not been published. The comparison has to be read across separate clinical trials run in different populations under different protocols, which limits what conclusions hold.
The STEP 1 trial of injectable semaglutide at 2.4mg/week found approximately 15% average body weight reduction at 68 weeks (published in the NEJM, 2021). The OASIS 1 trial of oral semaglutide at 50mg/week found approximately 15% average body weight reduction at 68 weeks (NEJM, 2023). Both used similar populations of adults with obesity or overweight with a weight-related comorbidity.
The commercial Wegovy pill doses top out at 25mg, not 50mg. Published efficacy data for the 25mg dose is still emerging. The FDA approved the pill based on the full dose range including 50mg; patients on the 25mg maintenance dose may see outcomes below the OASIS 1 headline.
Both formats use the same active molecule and the same mechanism of action. The difference is absorption efficiency. Injectable semaglutide delivers dose reliably under the skin. Oral semaglutide absorption is pH-dependent and averages about 1% of the dose absorbed, which is why the pill doses run 20-30x higher than injectable equivalents to achieve similar blood levels.
Which format fits which patient
Injectable semaglutide (compounded or branded) fits the patient who is tolerating injections, already getting results, and does not want to change what is working. Switching for cost makes sense if the injection path costs more than $299/month all-in and the needle is a persistent friction point.
The Wegovy pill fits the cash-pay patient who wants a branded, FDA-approved product at a lower price than the injection, and who can commit to the daily empty-stomach protocol. It does not fit the patient who takes morning medications, eats breakfast first, or frequently travels with variable schedules.
Tirzepatide (Zepbound or compounded) is the format for the patient who underresponded to semaglutide and wants a different mechanism. No oral tirzepatide is available; the injectable format is the only option. For patients who responded well to semaglutide, switching to tirzepatide for the pill-versus-shot reason is not supported by evidence.
Compounded semaglutide is the cash-pay format for the cost-limited patient who accepts the regulatory tradeoff and wants the same weekly injection schedule at $120-$220 less per month. It belongs in the decision: not FDA-approved as a finished product, supply is tied to pharmacy compliance, and the market is under active enforcement pressure.
Price watch: what changes soon
The NovoCare Wegovy injection intro is $199 a month for your first two fills. It applies to new patients at the 0.25mg and 0.5mg starter doses and runs through December 31, 2026. After that the standard cash price is $349 a month, or $399 for the 7.2mg high dose.
We track these prices every Monday. The GLP Chart Price Index shows the current all-in monthly cost across every US GLP-1 telehealth program, including programs that dispense the Wegovy pill.
Where to get the Wegovy pill
As of September 14, the following US telehealth programs dispense the oral Wegovy pill for weight management:
- Hims ($149/mo membership + NovoCare pill price; $448/mo all-in at maintenance, membership $39 first month)
- Ro Body ($149/mo membership month to month + NovoCare pill price; $448/mo all-in at maintenance, $373 if you prepay 12 months of membership)
- WeightWatchers Clinic ($25-$74/mo membership + NovoCare pill price; from about $323/mo all-in at maintenance on the 12-month plan)
- Noom Med (via branded telehealth tier, $99/mo + medication separate)
- Knownwell (care via insurance-billed primary-care visit; NovoCare pill pricing applies; visits may be covered separately by insurance)
- NovoCare Direct (no telehealth membership; $149/mo starter, $299/mo maintenance, prescription required)
The list is expanding as programs update their formularies. Check the GLP Chart homepage for current availability flags.
Frequently asked questions
What is the cheapest GLP-1 pill without insurance?
The lowest pill price on the chart is $99 a month for the Strut Health lozenge, on auto-refill, with a written medical reason you cannot use a needle. It is compounded semaglutide, a pharmacy-made version that is not FDA-approved and is not Wegovy or Ozempic. You hold it in your mouth. The two FDA-approved weight-loss pills, Wegovy and Foundayo, each cost $149 a month at the starter dose (1.5mg for Wegovy, 0.8mg for Foundayo).
Is there a GLP-1 pill with no membership fee?
Yes. Strut Health charges no membership fee for its lozenge, and the consult and shipping are in the monthly price. NovoCare sells the Wegovy pill straight to you with no membership once you have a prescription.
Is the pill cheaper than the shot?
Yes. Through NovoCare the Wegovy pill costs $50 a month less than the Wegovy shot at the dose you stay on, and $100 less than the 7.2mg shot. They match only in month two, when the 4mg pill costs $199 and so does a new patient's second fill of the shot on the intro offer, which runs through December 31, 2026.
Is the Wegovy pill the same as Rybelsus?
No. Both are semaglutide tablets made by Novo Nordisk. Rybelsus is approved for type 2 diabetes, and the Wegovy pill is approved for chronic weight management.
Can I get a GLP-1 pill online?
Yes. A US-licensed physician reviews Strut Health's online health form and prescribes the lozenge. Ro, Sesame Care and Hims prescribe the Wegovy pill online, and NovoCare sells it direct once you have a prescription.
See the live price of every GLP-1 program →
Read our compounded vs. branded cost study →
Compare GLP-1 drugs head to head (semaglutide vs tirzepatide, Wegovy vs Zepbound) →
Wegovy drug profile: dosing, efficacy, and prescribing criteria →
Wegovy pill side effects, from the FDA label →
Orforglipron (Foundayo), Lilly's GLP-1 pill: the 2026 buyer's guide →
